Business Description
Daiichi Sankyo is a Japanese pharmaceutical company founded in 1899 and headquartered in Tokyo, with operations across the United States, Europe, and other global markets. The company develops and sells a broad range of medicines covering cancer, heart disease, diabetes, bone health, pain, and neurological conditions, along with vaccines for illnesses such as influenza and COVID-19. Among its best-known products are Enhertu, a cancer treatment used for several HER2-positive tumor types, and a growing portfolio of drugs targeting blood disorders, iron deficiency, and migraine. The company also works with outside partners to advance research and improve how new treatments are discovered and developed.
